NASDAQ
Immage Biotherapeutics Corp. (IMMG) has a free cash flow growth of -1.22% as of Friday, May 29, 2026. This represents a 96.76% increase compared to its 12-month average of -37.65%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.